[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356110-105":59,"doc-detail-356110-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","case-report-pancreatic-amphicrine-like-carcinoma-with-acinar-differentiation-harboring-a-kank4-raf1-gene-fusion","Case Report - Pancreatic amphicrine-like carcinoma with acinar differentiation harboring a KANK4-RAF1 gene fusion","","Pancreatic amphicrine-like carcinoma (ALC) is a highly rare neoplasm combining exocrine and endocrine differentiation within the same tumour cells, creating a major diagnostic challenge against mixed neuroendocrine–non-neuroendocrine neoplasms. This report describes a case of pancreatic ALC with acinar differentiation harboring a KANK4::RAF1 fusion identified through comprehensive genomic profiling, with acinar marker expression and neuroendocrine marker co-expression in the same neoplastic population. RAF1 rearrangement was detected as a potentially actionable alteration. Despite systemic chemotherapy and initiation of trametinib, treatment was stopped after 1 month due to toxicity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/case-report-pancreatic-amphicrine-like-carcinoma-with-acinar-differentiation-harboring-a-kank4-raf1-gene-fusion/356110/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/case-report-pancreatic-amphicrine-like-carcinoma-with-acinar-differentiation-harboring-a-kank4-raf1-gene-fusion/356110.png","ImageObject",300,407,{"name":92,"@type":93},"OmBimo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What makes pancreatic amphicrine-like carcinoma (ALC) diagnostically challenging?","Question",{"text":112,"@type":113},"Pancreatic ALC is exceptionally rare and shows simultaneous exocrine and endocrine differentiation in the same tumour cells, which must be distinguished from mixed neuroendocrine–non-neuroendocrine neoplasms where the components are morphologically distinct.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genetic alteration was identified in the reported case?",{"text":117,"@type":113},"Comprehensive genomic profiling identified a KANK4::RAF1 fusion, accompanied by RAF1 rearrangement described as potentially actionable in a subset of pancreatic acinar carcinomas.",{"name":119,"@type":110,"acceptedAnswer":120},"Why was trametinib therapy discontinued in this case?",{"text":121,"@type":113},"Trametinib was started based on the presence of a RAF1 fusion, but it was discontinued after 1 month due to toxicity, preventing assessment of therapeutic efficacy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356110,1790925794,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Case Report  \nPUBLISHED 11 August 2026  \nDOI 10.3389/pore.2026.1612537  \nOPEN ACCESS  \nEDITED BY  \nAndrea Ladányi,  \nNational Institute of Oncology, Hungary  \n*CORRESPONDENCE  \nGuacimara Ortega Sanchez,  \n guacimara.ortegasanchez@ksw.ch †These authors have contributed equally to this work  \nRECEIVED 03 July 2026  \nREVISED 29 July 2026  \nACCEPTED 31 July 2026  \nPUBLISHED 11 August 2026  \nCITATION  \nKammerer S, Bode P, Schreiber H and Ortega Sanchez G (2026) Case Report:  \nPancreatic amphicrine-like carcinoma with acinar differentiation harboring a KANK4-RAF1 gene fusion.  \nPathol. Oncol. Res. 32:1612537 .  \ndoi: 10.3389/pore.2026.1612537  \nCOPYRIGHT  \n© 2026 Kammerer, Bode, Schreiber and Ortega Sanchez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCase Report: Pancreatic amphicrine-like carcinoma with acinar differentiation harboring a KANK4-RAF1 gene fusion  \nSabrina Kammerer 1†, Peter Bode 2†, Heide Schreiber 2 and Guacimara Ortega Sanchez 1*†  \n1Department of Medical Oncology and Hematology, Kantonsspital Winterthur, Switzerland, 2Department of Pathology, Kantonsspital Winterthur, Switzerland  \nPancreatic amphicrine-like carcinoma (ALC) is an exceptionally rare neoplasm characterized by simultaneous exocrine and endocrine differentiation within the same tumour cells. These tumours represent a diagnostic challenge because they must be distinguished from mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs), which consist of morphologically distinct tumour components. We report a case of pancreatic ALC with acinar differentiation harboring a KANK4::RAF1 fusion identified by comprehensive genomic profiling. Histologically, the tumour demonstrated acinar differentiation with expression of trypsin and BCL10 together with neuroendocrine differentiation characterized by synaptophysin and INSM1 expression within the same neoplastic population. Molecular analysis revealed a RAF1 rearrangement, a potentially actionable alteration previously described in a subset of pancreatic acinar carcinomas. The patient showed rapid disease progression despite systemic chemotherapy. Treatment with the MEK inhibitor trametinib was initiated based on the presence of a RAF1 fusion but was discontinued after 1 month because of toxicity, preventing assessment of therapeutic efficacy. This case expands the molecular spectrum of pancreatic ALC with acinar differentiation and highlights the importance of comprehensive molecular profiling in rare pancreatic neoplasms to identify potentially actionable genomic alterations.  \nKEYWORDS  \nacinar differentiation, exocrine and endocrine differentiation, KANK4::RAF1, metastatic, pancreatic amphicrine-like carcinoma  \nIntroduction  \nPancreatic epithelial neoplasms comprise a heterogeneous group of tumours with distinct morphological, immunophenotypic, and molecular characteristics. Although pancreatic ductal adenocarcinoma accounts for approximately 90% of malignant pancreatic tumors, several uncommon entities—including acinar cell carcinoma (ACC), pancreatic neuroendocrine tumors, pancreatoblastoma, and solid pseudopapillary neoplasms—display unique biological behavior and require different diagnostic and therapeutic approaches [ 1–3] .  \nAmphicrine-like carcinoma (ALC) of the pancreas is an exceptionally rare neoplasm characterized by the coexistence of exocrine and endocrine differentiation within the same neoplastic cells. This distinguishes it from mixed neuroendocrine–non-neuroendocrine neoplasms (MiNENs), in which the two components are morphologically distinct and represent separate tumour populati","cbCaipO9mkQsEcgZ","https://ap.wps.com/l/cbCaipO9mkQsEcgZ","pdf",2626642,"English","# Introduction\n## Amphicrine-like carcinoma and diagnostic distinction\n## Genomic profiling and RAF1 fusions\n# Case report\n## Presenting symptoms and laboratory findings","[{\"question\":\"What makes pancreatic amphicrine-like carcinoma (ALC) diagnostically challenging?\",\"answer\":\"Pancreatic ALC is exceptionally rare and shows simultaneous exocrine and endocrine differentiation in the same tumour cells, which must be distinguished from mixed neuroendocrine–non-neuroendocrine neoplasms where the components are morphologically distinct.\"},{\"question\":\"Which genetic alteration was identified in the reported case?\",\"answer\":\"Comprehensive genomic profiling identified a KANK4::RAF1 fusion, accompanied by RAF1 rearrangement described as potentially actionable in a subset of pancreatic acinar carcinomas.\"},{\"question\":\"Why was trametinib therapy discontinued in this case?\",\"answer\":\"Trametinib was started based on the presence of a RAF1 fusion, but it was discontinued after 1 month due to toxicity, preventing assessment of therapeutic efficacy.\"}]","Case Report - Pancreatic amphicrine-like carcinoma with acinar differentiation harboring a KANK4-RAF1 gene fusion | PDF",1790123434,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4e6bf97ef1a3970a9101d2f4d5e328a.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f7fccde5c8416402ad668f4a9485fb2.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3145a660ee57fdd0d59c4b3da3f888db.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/147d604a0da180dec0499a8cdf105de6.webp",980,1385]